Latest News (EN)

Adolfo Lutz Institute rules out Ebola in 37-year-old man; bacterial meningitis is confirmed in São Paulo

Ebola vírus
Photo: Ebola vírus - Corona Borealis Studio/shutterstock.com

Instituto Adolfo Lutz confirmed this Monday (1st) that it did not detect genetic material from the Ebola virus in the sample from the patient suspected of having the disease. Este result is crucial to allay concerns about a possible virus infection in the capital of São Paulo. The 37-year-old man remains hospitalized in serious condition at Instituto Emílio Ribas, a reference center for infectious diseases in São Paulo, receiving the necessary care from the medical team.

Secretaria Estadual from Saúde reported that, instead of Ebola, the tests showed meningococcal meningitis. Confirmation of meningitis provides clear direction for treatment and case management. The patient has a recent travel history to República Democrática of Congo, an area known to have Ebola cases, which initially raised the health alert and prompted the in-depth investigation.

Confirmação of meningococcal meningitis

Instituto Adolfo Lutz released on Saturday (30) the diagnosis of Neisseria meningitidis, the bacteria responsible for meningococcal meningitis. Essa identification was the result of a series of complex laboratory tests, which seek to differentiate pathogens in cases of high clinical suspicion. The speed in obtaining the result was essential for public safety and for the patient’s medical guidance, ruling out the most serious hypothesis of the Ebola virus.

Meningococcal meningitis is an inflammation of the membranes surrounding the brain and spinal cord and can be serious if not treated promptly. Initial symptoms, such as high fever, may be nonspecific, which makes differential diagnosis a challenge in situations where exotic diseases are suspected. The Instituto Emílio Ribas medical team is now focusing efforts on specifically treating the bacterial condition.

Patient Histórico and initial investigations

The 37-year-old man is originally from República Democrática of Congo, an African country where specific areas face Ebola transmission. Sua’s recent trip to this region was the main factor in activating epidemiological surveillance protocols. Chegando to Brasil, the patient sought medical attention after experiencing worrying symptoms.

Antes from being transferred to Instituto Emílio Ribas, he received first aid in an Unidade from Pronto Atendimento (UPA). Lá, the patient had a high fever and the preliminary tests carried out to identify malaria were inconclusive. Diante due to the persistence of symptoms and travel history, the suspicion of Ebola was raised and isolation and sample collection procedures were immediately initiated, following international health guidelines.

Protocolos epidemiological surveillance in São Paulo

The state of São Paulo maintains a rigorous surveillance system to detect and control infectious diseases. Casos suspected of high complexity or with epidemic potential are treated with extreme priority. Immediate communication to health authorities is a fundamental pillar of this system.

    Procedures for suspected cases include:

  • Comunicação urgent municipal epidemiological surveillance.
  • Fast Notificação to Centro from Vigilância Epidemiológica state.
  • Transferência for specialized reference units.
  • Coleta and sample analysis in accredited laboratories.
  • Acompanhamento of the patient’s clinical situation.

Instituto of Infectologia Emílio Ribas serves as the designated state referral unit for the care of patients with suspected or confirmed serious infectious diseases. Paralelamente, Instituto Adolfo Lutz is the central laboratory responsible for laboratory investigation and carrying out complex differential diagnoses, ensuring accurate results.

Condição current patient and critical care

Secretaria Estadual of Saúde reported that the 37-year-old patient’s health condition is considered serious. Ele remains hospitalized at Instituto Emílio Ribas, where he receives constant monitoring and intensive treatment for meningococcal meningitis. The medical team is committed to stabilizing the man’s clinical condition.

Care includes the administration of specific antibiotics to combat the Neisseria meningitidis bacteria and management of any complications that may arise due to the severity of the infection. The patient’s clinical condition is periodically reassessed, and health bulletins are issued as the case progresses. Health authorities continue to monitor the development of the situation, focusing on the patient’s recovery and preventing any risk to the community.